These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22725604)

  • 1. Editorial comment to suppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, Eviprostat, in a rat model of atherosclerosis-induced chronic bladder ischemia.
    Yamada S
    Int J Urol; 2012 Jul; 19(7):675; author reply 675. PubMed ID: 22725604
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, Eviprostat, in a rat model of atherosclerosis-induced chronic bladder ischemia.
    Matsui T; Oka M; Fukui T; Tanaka M; Oyama T; Sagawa K; Nomiya M; Yamaguchi O
    Int J Urol; 2012 Jul; 19(7):669-75. PubMed ID: 22458726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
    Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
    Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the phytotherapeutic agent eviprostat on the bladder in a rat model of bladder overdistension/emptying.
    Kawai Y; Oka M; Kyotani J; Oyama T; Matsumoto S; Kakizaki H
    Neurourol Urodyn; 2013 Sep; 32(7):1031-7. PubMed ID: 23143863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement by phytotherapeutic agent of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide induced cystitis.
    Nasrin S; Masuda E; Kugaya H; Ito Y; Yamada S
    J Urol; 2013 Mar; 189(3):1123-9. PubMed ID: 23000860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of bladder oxidative stress and inflammation by a phytotherapeutic agent in a rat model of partial bladder outlet obstruction.
    Oka M; Fukui T; Ueda M; Tagaya M; Oyama T; Tanaka M
    J Urol; 2009 Jul; 182(1):382-90. PubMed ID: 19447421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
    Sugimoto M; Oka M; Tsunemori H; Yamashita M; Kakehi Y
    Prostate; 2011 Mar; 71(4):438-44. PubMed ID: 21254154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasia.
    Matsumoto S; Hanai T; Matsui T; Oka M; Tanaka M; Uemura H
    Phytother Res; 2010 Feb; 24(2):301-3. PubMed ID: 19585469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate.
    Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M
    Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms by which a phytotherapeutic drug influences bladder activity in rats.
    Sugaya K; Nishijima S; Tasaki S; Kadekawa K; Miyazato M; Ogawa Y
    J Urol; 2008 Feb; 179(2):770-4. PubMed ID: 18082195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia.
    Nomiya M; Sagawa K; Yazaki J; Takahashi N; Kushida N; Haga N; Aikawa K; Matsui T; Oka M; Fukui T; Andersson KE; Yamaguchi O
    Neurourol Urodyn; 2012 Jan; 31(1):185-9. PubMed ID: 21953769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eviprostat suppresses proinflammatory gene expression in the prostate of rats with partial bladder-outlet obstruction: a genome-wide DNA microarray analysis.
    Tagaya M; Oka M; Ueda M; Takagaki K; Tanaka M; Ohgi T; Yano J
    Cytokine; 2009 Sep; 47(3):185-93. PubMed ID: 19616448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eviprostat activates cAMP signaling pathway and suppresses bladder smooth muscle cell proliferation.
    Li K; Yao J; Chi Y; Sawada N; Araki I; Kitamura M; Takeda M
    Int J Mol Sci; 2013 Jun; 14(6):12107-22. PubMed ID: 23743824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of atherosclerosis-induced chronic bladder ischemia on bladder function in the rat.
    Nomiya M; Yamaguchi O; Andersson KE; Sagawa K; Aikawa K; Shishido K; Yanagida T; Kushida N; Yazaki J; Takahashi N
    Neurourol Urodyn; 2012 Jan; 31(1):195-200. PubMed ID: 21905085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the phytotherapeutic agent Eviprostat on inflammatory changes and cytokine production in a rat model of nonbacterial prostatitis.
    Tsunemori H; Sugimoto M; Xia Z; Taoka R; Oka M; Kakehi Y
    Urology; 2011 Jun; 77(6):1507.e15-20. PubMed ID: 21624608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phytotherapeutic agent, eviprostat, suppresses stromal proliferation and inflammation even after establishment of nonbacterial prostatitis in the rat prostate.
    Shibuya S; Xia Z; Sugimoto M; Ueda N; Haba R; Kakehi Y
    Urology; 2014 Mar; 83(3):528-34. PubMed ID: 24581515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional consequences of chronic bladder ischemia.
    Yamaguchi O; Nomiya M; Andersson KE
    Neurourol Urodyn; 2014 Jan; 33(1):54-8. PubMed ID: 24292974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and neurodegeneration in the ischemic overactive bladder.
    Azadzoi KM; Yalla SV; Siroky MB
    J Urol; 2007 Aug; 178(2):710-5. PubMed ID: 17574610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of coenzyme Q10 on bladder dysfunction induced by chronic bladder ischemia in a rat model.
    Kim JW; Jang HA; Bae JH; Lee JG
    J Urol; 2013 Jun; 189(6):2371-6. PubMed ID: 23306086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of anti-reactive oxygen species activity to anti-inflammatory activity of components of eviprostat, a phytotherapeutic agent for benign prostatic hyperplasia.
    Oka M; Tachibana M; Noda K; Inoue N; Tanaka M; Kuwabara K
    Phytomedicine; 2007 Aug; 14(7-8):465-72. PubMed ID: 17583488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.